115 related articles for article (PubMed ID: 17201809)
1. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Jan; 66(1):110-4. PubMed ID: 17201809
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
Costa-Guda J; Rosen ED; Jensen RT; Chung DC; Arnold A
Clin Endocrinol (Oxf); 2005 May; 62(5):603-6. PubMed ID: 15853832
[TBL] [Abstract][Full Text] [Related]
3. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma.
Fujimoto A; Morita R; Hatta N; Takehara K; Takata M
Oncogene; 1999 Apr; 18(15):2527-32. PubMed ID: 10229204
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
[TBL] [Abstract][Full Text] [Related]
5. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of sporadic pancreatic endocrine tumours.
Perren A; Roth J; Muletta-Feurer S; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
J Pathol; 1998 Dec; 186(4):363-71. PubMed ID: 10209484
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
[TBL] [Abstract][Full Text] [Related]
9. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
Tobias ES; Hurlstone AF; MacKenzie E; McFarlane R; Black DM
Oncogene; 2001 May; 20(22):2844-53. PubMed ID: 11420696
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene.
Voelter-Mahlknecht S; Ho AD; Mahlknecht U
Int J Mol Med; 2005 Oct; 16(4):589-98. PubMed ID: 16142391
[TBL] [Abstract][Full Text] [Related]
12. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
14. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.
Hurlstone AF; Reid G; Reeves JR; Fraser J; Strathdee G; Rahilly M; Parkinson EK; Black DM
Oncogene; 1999 Mar; 18(10):1881-90. PubMed ID: 10086342
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
Takamochi K; Ogura T; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Suzuki K; Esumi H
Lung Cancer; 2004 Dec; 46(3):271-81. PubMed ID: 15541811
[TBL] [Abstract][Full Text] [Related]
18. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.
Shattuck TM; Kim TS; Costa J; Yandell DW; Imanishi Y; Palanisamy N; Gaz RD; Shoback D; Clark OH; Monchik JM; Wierman ME; Hollenberg A; Tojo K; Chaganti RS; Arnold A
Clin Endocrinol (Oxf); 2003 Aug; 59(2):180-9. PubMed ID: 12864795
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
20. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]